Fujifilm India has launched endoscopy manufacturing in Jodhpur, marking a major step toward local production of advanced medical devices. The move supports Make in India and aims to improve access to diagnostic technology.
India is stepping up its biomanufacturing ambitions by proposing a new working group with Delaware to boost collaboration in research, startups, and advanced biologics manufacturing.
NATCO Pharma launches generic Pomalidomide capsules in the US for blood and bone marrow cancer, strengthening its oncology portfolio and improving patient access to treatment.
The ongoing Gulf conflict is disrupting India’s medical tourism and pharma exports, causing flight cancellations, rising shipping costs, and delays that threaten revenue for hospitals and drug manufacturers.
MGM Healthcare has launched Swayam, Chennai's first comprehensive multidisciplinary geriatric programme. This structured continuity-of-care model integrates outpatient, inpatient, and home-based services to restore and sustain quality of life...
Complex generics and biosimilars are reshaping global pharma. As patents expire and demand rises, 2026 marks a turning point for innovation, competition, and access.
Lupin Limited has ranked among the top 1% globally in the S&P Global Corporate Sustainability Assessment, scoring 91 out of 100 and emerging as the top pharmaceutical company worldwide.
LTM has entered a seven-year, $100 million partnership with a leading European MedTech company specializing in hearing solutions, focusing on product development, digital support, and compliance management for hearing devices.
Mahajan Imaging & Labs reports an 85% rise in Calcium Scoring CT and 36% growth in advanced cardiac scans, highlighting early heart risk among young Indians and the need for preventive cardiology.
Dr Reddy's Laboratories is preparing to launch its generic semaglutide injection in India by March following patent expiry, aiming to offer a significantly lower-cost option for diabetes and weight-loss patients.